Skip to content
← Full study record

NCT01559935 · FLOW

Participant flow

Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma · Source last updated 2026-08-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) \[Car-BiRD\] Car Phase: carfilzomib: 45 mg/m2 IV on days 1, 2, 8, 9, 15 and 16 of each 28 day cycles. Dexamethasone: 20 mg orally on days 1, 2, 8, 9, 15 and 16 of a 28 day cycle, while receiving carfilzomib. BiRD Phase: Clarithromycin: 500 mg twice a day for each 28 day cycle of BiRD treatment. BiRD begins after carfilzomib treatment has been completed. Lenalidomide: 25 mg orally days 1-21 for each 28 day cycle of BiRD treatment. BiRD begins after carfilzomib treatment has been completed. Dexamethasone: 40 mg orally on days 1, 8, 15 and 22 of each 28 day cycle of BiRD treatment. BiRD begins after carfilzomib treatment has been completed. Maintenance Phase: Lenalidomide: 10 mg orally on days 1-21 or each 28 day cycle of maintenance. Maintenance begins after BiRD treatment has been completed.
    id
    FG000
    title
    Car-BiRD Therapy
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        4
      type
      Toxicity
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Death
    3. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Lack of Efficacy
    4. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Lost to Follow-up
    5. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Physician Decision
    6. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Withdrawal by Subject
    7. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Per protocol
    8. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Insurance
    9. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      non-compliance
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        72
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        58
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        14
      type
      NOT COMPLETED
    title
    Car Phase
  2. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Toxicity
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Lack of Efficacy
    3. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Withdrawal by Subject
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        58
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        54
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        4
      type
      NOT COMPLETED
    title
    BiRD Phase
  3. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        28
      type
      Remains on study
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Toxicity
    3. reasons
      1. group Id
        FG000
        num Subjects
        18
      type
      Lack of Efficacy
    4. reasons
      1. group Id
        FG000
        num Subjects
        5
      type
      Withdrawal by Subject
    5. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Non-compliance
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        54
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        54
      type
      NOT COMPLETED
    title
    Maintenance Phase
pre Assignment Details
Two subjects were ineligible and therefore never started treatment.
Complete source fields
groups
  1. description
    Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) \[Car-BiRD\] Car Phase: carfilzomib: 45 mg/m2 IV on days 1, 2, 8, 9, 15 and 16 of each 28 day cycles. Dexamethasone: 20 mg orally on days 1, 2, 8, 9, 15 and 16 of a 28 day cycle, while receiving carfilzomib. BiRD Phase: Clarithromycin: 500 mg twice a day for each 28 day cycle of BiRD treatment. BiRD begins after carfilzomib treatment has been completed. Lenalidomide: 25 mg orally days 1-21 for each 28 day cycle of BiRD treatment. BiRD begins after carfilzomib treatment has been completed. Dexamethasone: 40 mg orally on days 1, 8, 15 and 22 of each 28 day cycle of BiRD treatment. BiRD begins after carfilzomib treatment has been completed. Maintenance Phase: Lenalidomide: 10 mg orally on days 1-21 or each 28 day cycle of maintenance. Maintenance begins after BiRD treatment has been completed.
    id
    FG000
    title
    Car-BiRD Therapy
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        4
      type
      Toxicity
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Death
    3. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Lack of Efficacy
    4. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Lost to Follow-up
    5. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Physician Decision
    6. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Withdrawal by Subject
    7. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Per protocol
    8. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Insurance
    9. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      non-compliance
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        72
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        58
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        14
      type
      NOT COMPLETED
    title
    Car Phase
  2. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Toxicity
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Lack of Efficacy
    3. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Withdrawal by Subject
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        58
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        54
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        4
      type
      NOT COMPLETED
    title
    BiRD Phase
  3. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        28
      type
      Remains on study
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      type
      Toxicity
    3. reasons
      1. group Id
        FG000
        num Subjects
        18
      type
      Lack of Efficacy
    4. reasons
      1. group Id
        FG000
        num Subjects
        5
      type
      Withdrawal by Subject
    5. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Non-compliance
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        54
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        54
      type
      NOT COMPLETED
    title
    Maintenance Phase
pre Assignment Details
Two subjects were ineligible and therefore never started treatment.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice